8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed Nov 9, 2023 · 2y ago · Accession 0001193125-23-274124
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Nov 9, 2023
- Report date
- Nov 9, 2023
- Document
- d591379d8k.htm
- Size
- 18.8 MB